ĀÜĄņĀŅĀ×

Josh Resnick is a Managing Director at RA Capital Management. Josh holds a BA in Chemistry from Williams College, an MD from the University of Pennsylvania School of Medicine, and an MBA from the Wharton School of Business. He has more than 15 years of experience in investing, company formation, and company leadership across all stages of drug development, from discovery through commercialisation. Josh was previously co-lead of SV Health Investorsā€™ US Biotech practice, and prior to that was President and Managing Partner at MRL Ventures Fund. Prior to MRL Ventures, he was a Venture Partner with Atlas Venture and a Partner at Prism Venture Partners. Josh is currently a faculty member at Harvard Medical School and continues to practice medicine as an attending physician in the Department of Emergency Medicine at Massachusetts General Hospital.